Notice of Proposed Sale · 144
CG Oncology, Inc.
CGONNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- CG ONCOLOGY, INC.
- Issuer CIK
- 0001991792
- SEC file number
- 001-41925
- Phone
- (949) 409-3700
- Person for whose account securities are to be sold
- AMBAW BELLETE
- Relationships to issuer
- Officer
- Street
- 3000 Pegasus Park Drive
- Street (continued)
- SUITE 1640
- City
- Dallas
- State / country code
- TX
- Postal code
- 75247
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 4,303 | 316,270.50 | 88,202,473 | 07/29/2026 | NASDAQ | Morgan Stanley Smith Barney LLC Executive Financial Services |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Street
- 1 New York Plaza
- Street (continued)
- 8th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 07/29/2026 | Stock Option Exercise | Issuer | 4,303 | N | 07/29/2026 | Cash |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| AMBAW BELLETE | Common | 07/28/2026 | 50,000 | 3,625,195.00 |
| AMBAW BELLETE | Common | 07/27/2026 | 50,000 | 3,627,995.00 |
| AMBAW BELLETE | Common | 07/23/2026 | 50,000 | 3,588,620.00 |
| AMBAW BELLETE | Common | 07/15/2026 | 52,438 | 3,816,007.65 |
Seller — prior-sale row 1, entry 1
- Name
- AMBAW BELLETE
- Street
- 3000 Pegasus Park Drive
- Street (continued)
- SUITE 1640
- City
- Dallas
- State / country code
- TX
- Postal code
- 75247
Seller — prior-sale row 2, entry 1
- Name
- AMBAW BELLETE
- Street
- 3000 Pegasus Park Drive
- Street (continued)
- SUITE 1640
- City
- Dallas
- State / country code
- TX
- Postal code
- 75247
Seller — prior-sale row 3, entry 1
- Name
- AMBAW BELLETE
- Street
- 3000 Pegasus Park Drive
- Street (continued)
- SUITE 1640
- City
- Dallas
- State / country code
- TX
- Postal code
- 75247
Seller — prior-sale row 4, entry 1
- Name
- AMBAW BELLETE
- Street
- 3000 Pegasus Park Drive
- Street (continued)
- SUITE 1640
- City
- Dallas
- State / country code
- TX
- Postal code
- 75247
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Notice signature
- Notice date
- 07/29/2026
- Signed
- /s/ Ambaw Bellete
Company context
CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology sees a world where urologic cancer patients may benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. To learn more, please visit: www.cgoncology.com.